Takeda Exercises Rights to License Agreement on Alizyme's Obesity ...
Osaka, Japan, January 30, 2004 --- Takeda Chemical Industries, Ltd. ("Takeda", 4502: Tokyo Stock Exchange) announced today that it has exercised the rights ...
http://www.takeda.com/press/article_807.html...
|
BioPortfolio - Alizyme Therapeutics Limited
Alizyme Therapeutics Limited - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/364-Alizyme_Therape...
|
BioSpace - Alizyme PLC News, Search Jobs, Events
Alizyme PLC 280 Cambridge Science Park Milton Road ... Alizyme PLC (AZM.L) Commencement of Phase 2 Study in the U.S. 5/20/2008 12:51:41 PM More. ...
http://www.biospace.com/company_profile.aspx?CompanyId=3914...
|
BioPortfolio - alizyme therapeutics careers
alizyme therapeutics careers - BioPortfolio. ... Alizyme Therapeutics Limited - Entry on Bioportfolio's Biocorporate Database. ... www.alizyme . com . ...
http://www.bioportfolio.com/search/alizyme_therapeutics_care...
|
BioWorld Today
LONDON - Alizyme plc landed the speciality pharma company Norgine BV as a European marketing partner for Colal-Pred, its treatment for ulcerative colitis.
...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...
|
BioPortfolio - Alizyme Therapeutics Limited - Profile
View the current Alizyme Therapeutics Limited Page on BioPortfolio.com ... Alizyme is a drug development company. It develops new products to treat
diseases ...
http://www.bioportfolio.com/biocorporate/364-Alizyme+Therape...
|
BioMed Central | PDF | COLAL-PRED (Alizyme)
COLAL-PRED (Alizyme) SB Hanauer, M Sparrow Current Opinion in Investigational Drugs 2004 5:1192-1197. Access to the full text of this article requires a ...
http://www.biomedcentral.com/content/pdf/cd-568486.pdf...
|
COLAL-PRED Alizyme.
COLAL-PRED (prednisolone sodium metasulfobenzoate), which is targeted to the colon by COLAL colonic drug delivery technology, is being developed by Alizyme
...
http://www.ncbi.nlm.nih.gov/pubmed/15573870...
|
BioPortfolio - BioPortfolio - Alizyme Therapeutics Limited
BioPortfolio - Alizyme Therapeutics Limited - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/364/www.ali...
|
BioWorld Today
30 Apr 2008 ... Alizyme Kills Renzapride After Phase III Failure ... LONDON - Alizyme plc axed its Phase III irritable bowel syndrome treatment Renzapride ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...
|
